基线定量心电图参数不能完全预测布鲁加达患者的第1类抗失律作用:布鲁加达患者的药物诱导的心电图变化
Pierre-Léo Laporte1, Martino Vaglio2, Isabelle Denjoy1
1Reference Center for Inherited Arrhythmic Syndromes, Hôpital Bichat, APHP, Université Paris Cité, Paris, France.
Journal of electrocardiology
|July 31, 2025
概括
药物挑战测试通过显示ST升高来有效识别布鲁加达综合征 (BS),但其对QRS持续时间的影响不太可预测. 基线心电图特征会影响对通道阻塞的反应.
科学领域:
- 心脏病学 心脏病学
- 电子生理学 电子生理学
- 遗传学 遗传学 是一个
背景情况:
- 药物挑战测试对于诊断布鲁加达综合征 (BS) 在缺乏自发型1型心电图模式的患者中至关重要.
- 一类抗心律失常药物挑战可能是不可预测的,并带有风险.
研究的目的:
- 为了评估患者对I类抗失常药物挑战的反应.
- 分析基线心电图参数与布鲁加达综合征患者药物诱导的变化之间的相关性.
主要方法:
- 利用法国MUTAVIT注册表中157名接受药物诱导BS测试的患者的数字化心电图数据.
- 量化12导心电图参数 (V1-V3),重点关注QRS持续时间和ST段升高,在药物给药前后.
主要成果:
- 药物挑战显著延长了QRS持续时间和增加了ST振幅,特别是在V2.
- 基线ST升高与药物诱导的ST升高的大小有很强的相关性.
- 在药物中QRS持续时间与基线QRS持续时间的相关性很弱;SCN5A变异携带者基线QRS较长,但在挑战期间没有.
结论:
- 在通道阻塞期间ST升高的幅度与基线ST幅度相关.
- 药物对QRS持续时间的影响与基线QRS持续时间仅略有相关.
- 致病性SCN5A变异影响基线心电图特征和对通道阻塞的反应.
更多相关视频
相关概念视频
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
859
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
859
Dysrhythmias IV: Characteristics of Bradyarrhythmias
120
Bradyarrhythmias are cardiac rhythm disorders characterized by a slower-than-normal heart rate, typically defined as fewer than 60 beats per minute. Some of which are discussed here:Sinus BradycardiaSinus bradycardia presents a heart rate lower than 60 beats per minute, with a regular rhythm originating from the SA node. The ECG typically shows normal P waves preceding each QRS complex, a normal PR interval (0.12 to 0.20 seconds), and a normal QRS duration (0.06 to 0.10 seconds).First-Degree AV...
120
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
1.7K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.7K
ECG Interpretation of Arrhythmias I: Sinus Arrhythmias
414
Arrhythmias are disturbances in the heart's rhythm that lead to abnormal heartbeats. These irregularities can originate from different parts of the heart and are classified based on their origin and nature.
Types of Arrhythmias
Sinus Node Arrhythmias
Sinus Bradycardia: Originating from the sinoatrial (SA) node, sinus bradycardia involves slower impulses, resulting in a heart rate of less than 60 beats per minute (bpm). Causes include sleep, vagal stimulation, beta-blockers, hypothyroidism,...
Types of Arrhythmias
Sinus Node Arrhythmias
Sinus Bradycardia: Originating from the sinoatrial (SA) node, sinus bradycardia involves slower impulses, resulting in a heart rate of less than 60 beats per minute (bpm). Causes include sleep, vagal stimulation, beta-blockers, hypothyroidism,...
414
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
168
Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
168
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
1.2K
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
1.2K


